Officer of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL), recently purchased 20,000 shares of the company's common stock. The shares were acquired at a price of $2.2828 each, totaling $45,656.

In the eyes of Tesla shareholders, Elon Musk hardly needed another distraction. OpenAI could turn out to be a costly one.

TORONTO - Waste Connections, Inc. (TSX/NYSE: NYSE:WCN), a North American integrated waste services company with a market ...

Amgen, Inc. ( NASDAQ: AMGN) Oppenheimer 35th Annual Healthcare Life Sciences Conference Call February 12, 2025 11:20 AM ET Narimon Honarpour - Senior Vice President, Global Development Justin Claeys - ...

Johnny Depp as Captain Jack Sparrow? Robert Downey Jr. in "Tropic Thunder"? You'd be shocked by the roles that have received ...

The leftist party of former leader Rafael Correa, a Venezuelan ally, could return to power. Here’s what’s at stake ...

OpenAI was cofounded by Musk and Altman in 2018 as a non-profit, with Musk leaving before the company took off. Musk’s ...

Tesla (TSLA) is advancing 3% after investment bank Benchmark started coverage of the automaker with a Buy rating.

December, making it the worst performer among the top stocks. Investors are concerned about CEO Elon Musk's political ...

Oppenheimer analyst Owen Lau maintained a Buy rating on S&P Global (SPGI – Research Report) today and set a price target of $610.00. The ...

In a report released today, Matthew Biegler from Oppenheimer reiterated a Buy rating on Gilead Sciences (GILD – Research Report), with a price ...

Analysts at Oppenheimer said in a research note on Tuesday that billionaire Elon Musk's recent bid for ChatGPT parent OpenAI ...